News from the healthcare data industry
July 2, 2022 Rose McNulty Real-world patients often differ from those eligible for clinical trials, and comparing results in both populations is a key step in fine-tuning treatment strategies for multiple myeloma. Populations in clinical trials and real-world patients are often different, and multiple myeloma (MM) trials are no exception. Considering the…
Fortune partnered with Merative on the 2022 ranking of the 100 Top Hospitals and the 15 Top Health Systems in the U.S. Learn more about the lists and see which community and teaching hospitals ranked high among their peers below. 100 Top Hospitals: Introduction 40 Top Teaching Hospitals 60 Top Community…
Executive Summary Neurodegenerative and cardiovascular diseases, along with cancer and early feasibility studies, are among the topics to be addressed by consortia interested in taking part in the EU’s latest research partnership.Source: Shutterstock/Vladimir SukhachevTHE EU’S IHI IS SEEKING NEW APPROACHES TO INNOVATIVE TREATMENTS Europe’s public-private partnership, the Innovative Health Initiative,…
Rep. Doris Matsui announces federal funding for the creation of a regional digital public health platform (SACRAMENTO) On Monday, Rep. Doris Matsui (CA-06) announced $1.7 million of federal funding for UC Davis Health’s Digital Health Equity Program at a press conference on the Sacramento campus. The federal funding, which Matsui championed as…
by Vivian DeWoskin, VP, Life Sciences Strategy June 30, 2022 Topics: Perspectives, Commercial, Race and Ethnicity, Health Equity While the last two years of pandemic-driven disruption have spotlighted race-based disparities in healthcare, the problem is not a new one. Populations of color have been persistently under-represented and have consistently experienced worse outcomes and higher disease risk for…
Jun 30, 2022 | staff reporter NEW YORK – A pan-cancer analysis involving tens of thousands of patients has spelled out new and known relationships between tumor mutations, survival outcomes, and responses to a range of cancer treatment strategies. “This work demonstrates how computational analysis of large real-world data can facilitate precision…
Abstract Quantifying the effectiveness of different cancer therapies in patients with specific tumor mutations is critical for improving patient outcomes and advancing precision medicine. Here we perform a large-scale computational analysis of 40,903 US patients with cancer who have detailed mutation profiles, treatment sequences and outcomes derived from electronic health…
A survey found that nearly half of all Americans are unable to get health records when needed, underscoring patient data access barriers that could impact patient health outcomes. By Sarai Rodriguez June 30, 2022 – Even though the vast majority of Americans want quick patient data access, many of them struggle to obtain…
Executive Summary England’s health technology appraisal institute, NICE, has published its real-world evidence framework.NICE LAUNCHES RWE FRAMEWORK With its newly published real-world evidence (RWE) framework, NICE, England’s health technology appraisal (HTA) institute, is making “a real push into real-world data in a big way,” Sam Roberts, NICE’s chief executive, said…
Health care providers collect vast amounts of electronic health information (EHI) that hold enormous potential for advancing science. However, that potential has been limited by a lack of incentives, imperatives, and standardized means to share EHI with researchers. Federal law sets conditions for sharing identifiable data for research through regulations under…